Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Amsterdam  >  Royal DSM N.V.    DSM   NL0000009827

ROYAL DSM N.V.

(DSM)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Amsterdam
10/26/2020 10/27/2020 10/28/2020 10/29/2020 10/30/2020 Date
138.95(c) 140.35(c) 137.1(c) 137.2(c) 137.45(c) Last
319 307 292 836 419 113 438 337 407 609 Volume
-1.66% +1.01% -2.32% +0.07% +0.18% Change
More quotes
Financials
Sales 2020 8 924 M 10 392 M 10 392 M
Net income 2020 692 M 805 M 805 M
Net Debt 2020 2 793 M 3 253 M 3 253 M
P/E ratio 2020 34,6x
Yield 2020 1,81%
Sales 2021 9 466 M 11 023 M 11 023 M
Net income 2021 881 M 1 025 M 1 025 M
Net Debt 2021 2 186 M 2 546 M 2 546 M
P/E ratio 2021 26,4x
Yield 2021 1,88%
Capitalization 23 308 M 27 162 M 27 142 M
EV / Sales 2020 2,92x
EV / Sales 2021 2,69x
Nbr of Employees 21 940
Free-Float 94,7%
More Financials
Company
Royal DSM specializes in the development, manufacture and marketing of performance materials, and nutritional and pharmaceutical ingredients. The products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics. Net sales (not including sold divisions) by... 
Sector
Diversified Chemicals
Calendar
11/03 | 07:00amErgebnisveröffentlichung
More about the company
Notations Surperformance© of Royal DSM N.V.
Trading Rating : Investor Rating :
More Ratings
All news about ROYAL DSM N.V.
10/29ROYAL DSM N.V. : quaterly earnings release
10/29ROYAL DSM N : DSM update on vitamin E production
PU
10/29ROYAL DSM N : DSM unveils purpose-led brand strategy marking transition to end-t..
PU
10/27Covestro reports third-quarter profit beat on strong Asia, furniture units
RE
10/02ROYAL DSM N : DSM completes acquisition of Erber Group
PU
09/30EUROPE : European stocks end choppy September with a whimper
RE
09/30Covestro buys DSM's resins unit for 1.6 billion euros
RE
09/30Covestro buys DSM's resins unit for 1.6 bln euros
RE
09/30ROYAL DSM N : DSM announces sale of Resins & Functional Materials businesses
PU
09/28ROYAL DSM N.V. : Crossing thresholds
CO
09/25ROYAL DSM N.V. : Crossing thresholds
CO
09/24ROYAL DSM N : DSM proposes new Supervisory Board member
PU
09/22Government Initiatives to Push the Global Direct-fed Microbials Market to Gar..
AQ
09/18What is the science behind the moo-ve from cattle methane emissions?
RE
09/18BURPS TO BURGERS : food companies wrangle climate-warming cattle emissions
RE
More news
News in other languages on ROYAL DSM N.V.
10/29ROYAL DSM N.V. : Veröffentlichung des Quartalsergebnisses
10/29ROYAL DSM N.V. : publication des résultats trimestriels
10/14Covestro sammelt 447 Millionen Euro frisches Kapital ein
10/13Covestro will mit Kapitalerhöhung 450 Millionen Euro einnehmen
10/09Covestro wird für 2020 optimistischer - Aktie kaum verändert
More news
Chart ROYAL DSM N.V.
Duration : Period :
Royal DSM N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL DSM N.V.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 143,44 €
Last Close Price 137,45 €
Spread / Highest target 25,1%
Spread / Average Target 4,36%
Spread / Lowest Target -43,3%
EPS Revisions
Managers
NameTitle
Dimitri de Vreeze Co-Chief Executive Officer & COO
Géraldine Matchett Co-Chief Executive Officer & CFO
Robert John Routs Chairman-Supervisory Board
Pauline F. M. van der Meer Mohr Deputy Chairman
Eileen A. Kennedy Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
ROYAL DSM N.V.18.39%27 162
SHIN-ETSU CHEMICAL CO., LTD.15.17%55 152
BASF SE-30.11%50 382
DUPONT DE NEMOURS, INC.-11.40%42 534
FMC CORPORATION2.93%13 427
ASAHI KASEI CORPORATION-27.03%11 946